Cue Biopharma Inc Institutional ownership
What is the Institutional ownership of Cue Biopharma Inc?
The Institutional ownership of Cue Biopharma Inc is 50.56%
What is the definition of Institutional ownership?
Institutional Ownership is the amount of a company’s available stock owned by mutual or pension funds, insurance companies, investment firms, endowments or other large entities that manage funds on the behalf of others.
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
Institutional ownership of companies in the Health Care sector on NASDAQ compared to Cue Biopharma Inc
What does Cue Biopharma Inc do?
cue biopharma is an innovative immunotherapy company developing a novel, proprietary class of biologics engineered to selectively modulate the human immune system to treat a broad range of cancers and autoimmune disorders. we design biologics to engage and modulate the activity of disease-associated t cells in the patient’s body, offering significant therapeutic advantages while potentially minimizing or eliminating unwanted side effects. we believe our biologics allow us to target antigen-specific t cell populations in a variety of indications using a simple peptide exchange within previously-validated drug frameworks developed from the cue biologics platform. this flexibility could truncate the drug selection and development process, moving effective therapeutics from discovery to clinical validation more rapidly and cost efficiently than current industry standard timelines and costs. headquartered in kendall square, cambridge, ma, we are led by an experienced management team and sci
Companies with institutional ownership similar to Cue Biopharma Inc
- Aptinyx Inc has Institutional ownership of 50.50%
- 56728 has Institutional ownership of 50.51%
- Calamos Convertible and High Income Fund has Institutional ownership of 50.51%
- Aritzia has Institutional ownership of 50.52%
- Eos Enterprises has Institutional ownership of 50.52%
- Shurgard Self Storage S.A has Institutional ownership of 50.54%
- Cue Biopharma Inc has Institutional ownership of 50.56%
- Danimer Scientific has Institutional ownership of 50.57%
- NB Global Floating Rate Income Fund has Institutional ownership of 50.58%
- ASOS Plc has Institutional ownership of 50.58%
- HeadHunter PLC has Institutional ownership of 50.60%
- Midas Gold has Institutional ownership of 50.61%
- Midas Gold has Institutional ownership of 50.61%